Fusion event
HBV-TMEM132D integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAG| |GCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTG
End
129937949/129453404 (Hg38)
Nearest miRNA
hsa-let-7i/Upstream/1159226; hsa-mir-6763/Downstream/3128593;
Upstream sequence
TTTTGCAGCATGGGCTACTGGCTTTTGCGCAAGGTGTCTCTTTGCCTGGAATTCCCTCCCGCAGGGTCCCATCCTTTCTAAATCCAAACTGCATTCAAAG
Downstream sequence
AAAGGGCTAAGTCTGCTCCTTTCAACTGGAGAGTTCCTTTTCTACTAACAGCACAATTTTTATATTAtttggctacaaatgatggaaacctcacactctc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.